Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. 2002

Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
AIDS Pathogenesis Research Unit, Macfarlane Burnet Institute for Medical Research and Public Health, G.P.O. Box 2284, Melbourne, Victoria 3004, Australia. sonza@burnet.edu.au

The transcription and splicing of human immunodeficiency virus type 1 (HIV-1) mRNA in primary blood monocyte-derived macrophages (MDM) and CD4(+) peripheral blood lymphocytes (PBL) were compared to determine whether any differences might account for the slower noncytopathic infection of cells of the macrophage lineage. The expression of regulatory mRNAs during acute infection of MDM was delayed by about 12 h compared to that of PBL. In each cell type, an increase in spliced viral mRNAs slightly preceded virus production from the culture. Following the peak of productive infection, there was a proportional decrease in the expression of all regulatory mRNAs detected in PBL. In MDM, a dramatic additional decrease specifically in the tat mRNA species heralded a reduction in virus production. This decline in tat mRNA was reflected by a concomitant decrease in Tat activity in the cells and occurred with the same kinetics irrespective of the age of the cells when infected. Addition of exogenous Tat protein elicited a burst of virus production from persistently infected MDM, suggesting that the decrease in virus production from the cultures is a consequence of the reduction in tat mRNA levels. Our results show that modulation of HIV-1 mRNAs in macrophages during long-term infection, which is dependent on the period of infection rather than cell differentiation or maturation, results in a selective reduction of Tat protein levels at the commencement of a persistent, less productive phase of infection. Determination of the mechanism of this mRNA modulation may lead to novel targets for control of replication in these important viral reservoirs.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012326 RNA Splicing The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. RNA, Messenger, Splicing,Splicing, RNA,RNA Splicings,Splicings, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
May 1995, Journal of virology,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
January 1992, Journal of virology,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
July 1993, The Journal of infectious diseases,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
February 1994, Virology,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
April 1994, The Journal of infectious diseases,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
August 1998, Journal of virology,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
January 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
June 1994, Chemico-biological interactions,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
February 2015, Virology,
Secondo Sonza, and Helen P Mutimer, and Kate O'Brien, and Philip Ellery, and Jane L Howard, and Jonathan H Axelrod, and Nicholas J Deacon, and Suzanne M Crowe, and Damian F J Purcell
November 1996, Journal of virology,
Copied contents to your clipboard!